LifeScience

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody

The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...

 August 10, 2021 | News

Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to tradi...

 August 10, 2021 | News

GenScript to provide the mutant libraries construction to Allozymes

GenScript Biotech Corporation today announced a collaboration with Allozymes, a synthetic biology company transforming ingredient manufacturing by unlockin...

 August 04, 2021 | News

Glenmark,SaNOtize to commercialize Nasal Spray for COVID-19 treatment in Asia

Nitric oxide has antimicrobial properties with direct proven effect on SARS-CoV-2 Nitric Oxide Nasal Spray (NONS) has been tested in healthy volunteers ...

 August 03, 2021 | News

Sartorius Stedim Biotech acquires cell culture specialist Xell AG

- Extension of the Sartorius Stedim Biotech cell culture media business with a focus on media for gene therapeutics and vaccines Significant expansion o...

 July 29, 2021 | News

GenScript cPass SARS-COV-2 Neutralization Antibody Detection Kit

GenScript Biotech Corporation, a world-leading life sciences research and application service and product provider, announced today that the...

 July 28, 2021 | News

LifeSignals receives FDA 510 (k) Approval

LifeSignals Inc., today announced it has received FDA Class II 510 (k) approval for the LifeSignals LX1550 Multiparameter Remote Monitoring Platform. This ...

 July 28, 2021 | News

Biocon Biologics to Manufacture and Commercialize a Broadly Neutralizing Antibody for India and Select Emerging Markets

Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. , announced today that U.S. based Adagio Therapeutics has gra...

 July 26, 2021 | News

LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic

LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...

 July 26, 2021 | News

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack

 Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS&...

 July 23, 2021 | News

GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership

The agreement outlines a constructive framework where GenFleet will synergize its own R&D systems with Insilico's end-to-end AI-powered drug discovery ...

 July 21, 2021 | News

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...

 July 20, 2021 | News

Batavia BioScience produces first clinical product with HIP-VAX platform

Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa...

 July 15, 2021 | News

Enzymatica and STADA extend agreement on ViruProtect to Vietnam

Enzymatica has licensed to STADA exclusive rights to market and sell ViruProtect® (distributed by Enzymatica as ColdZyme®) in Vietnam. ...

 July 14, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close